Simon Chandler Email

CEO and Director . Rinri Therapeutics

Current Roles

Employees:
16
Revenue:
$1.2M
About
Rinri Therapeutics is a private biotechnology company developing first-in-class cell therapies to restore hearing. Hearing loss affects 350m people in the world; 90% caused by sensorineural hearing loss (SNHL). There are currently no disease-modifying therapeutics for SNHL patients. Rinri's pioneering technology seeks to reverse SNHL through the regeneration of the damaged sensory cells in the inner ear, the cochlea. Rinri is backed by Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, BioCity and the University of Sheffield.
Rinri Therapeutics Address
Innovation Centre 217 Portobello
Sheffield, null
Rinri Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.